Foresite Capital Fund IV, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Maze Therapeutics, Inc. Common Stock, par value $0.001 (MAZE)

Filing Manager
Foresite Capital Fund IV, L.P.
Reporting Manager
James Tananbaum
Security
Maze Therapeutics, Inc. Common Stock, par value $0.001
Symbol
MAZE
Shares outstanding
43,496,286 shares
Disclosed Ownership
608,948 shares
Ownership
1.4%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:04:27 UTC
Date of event
30 Sep 2025
Previous filing
07 Feb 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Foresite Capital Fund IV, L.P. 1.2% 522,657 522,657 0 /s/ James Tananbaum James Tananbaum, Managing Member of the General Partner
Foresite Capital Management IV, LLC 1.2% 522,657 522,657 0 /s/ James Tananbaum James Tananbaum, Managing Member
Foresite Capital Fund V, L.P. 0.2% 86,291 86,291 0 /s/ James Tananbaum James Tananbaum, Managing Member of the General Partner
Foresite Capital Management V, LLC 0.2% 86,291 86,291 0 /s/ James Tananbaum James Tananbaum, Managing Member
James Tananbaum 1.4% 608,948 608,948 0 /s/ James Tananbaum James Tananbaum